Jörg Friess und Fingolimod - Info zur Person

(1 - 4 von 4

)

Fingolimod alters the transcriptome profile of circulating CD4+ cells...

www.nature.com

· Jörg Friess and Michael Hecker: These authors contributed equally to this work. Affiliations. Department of Neurology, Division of ...

Fingolimod alters the transcriptome profile of circulating CD4+ cells...

www.ncbi.nlm.nih.gov

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis. Jörg Friess,1,* Michael Hecker,a,1,2,* Luisa Roch,1 Dirk Koczan,2,3 Brit Fitzner,2 Ines Charlotte Angerer,1 Ina Schröder,1 Kristin Flechtner,3 Hans-Jürgen Thiesen,2,3 Alexander Winkelmann,1 and Uwe Klaus Zettl1.

Transcriptome profiling of peripheral blood immune cell populations...

pubmed.ncbi.nlm.nih.gov

Our study corroborates changes in the composition of circulating immune cells in response to fingolimod and delineates the respective implications at the RNA...